U.S. Markets open in 1 hr 50 mins

UK's GlaxoSmithKline aims to market first malaria vaccine

British drug maker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed it significantly cut cases of the disease in African children. As Joanna Partridge reports it will be welcome news for a UK company recently battered by a corruption scandal in China.